Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.60 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.60 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | LCK | P06239 | 1/20 | 0.48 |
| ▸ | PPARD | Q03181 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.46 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.43 |
| ▸ | GMNN | O75496 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1237975 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL425589 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL165537 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL168064 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL167865 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL17646227 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL167222 | 1.00 | GPR84 (0.60) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL5740376 | 0.98 | GPR84 (0.57) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL2858482 | 0.96 | GPR84 (0.56) | GPR84FFAR1MAPTLCKPPARD | |
| SCHEMBL6910867 | 0.95 | GPR84 (0.55) | GPR84FFAR1MAPTLCKPPARD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1053 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12611407-B2 | Gastro-resistant high-strength formulation containing posaconazole | ALFRED E. TIEFENBACHER (GMBH & CO. KG) (DE) | 2026-04-28 | — | — | US | claimed |
| EP-4181883-B1 | GRANULES CONTAINING POSACONAZOLE | TIEFENBACHER ALFRED E GMBH & CO KG (DE) | 2025-11-19 | — | — | EP | claimed |
| US-20240390363-A1 | GRANULES CONTAINING POSACONAZOLE | ALFRED E. TIEFENBACHER (GMBH AND CO. KG) (DE) | 2024-11-28 | — | — | US | claimed |
| EP-3590505-B1 | GASTRO-RESISTANT FORMULATION CONTAINING POSACONAZOLE | TIEFENBACHER ALFRED E GMBH & CO KG (DE) | 2024-11-06 | — | — | EP | claimed |
| US-20240293399-A1 | GASTRO-RESISTANT HIGH-STRENGTH FORMULATION CONTAINING POSACONAZOLE | ALFRED E. TIEFENBACHER GMBH & CO. KG (DE) | 2024-09-05 | — | — | US | claimed |
| EP-4091604-B1 | GRANULES CONTAINING POSACONAZOLE | TIEFENBACHER ALFRED E GMBH & CO KG (DE) | 2024-04-03 | — | — | EP | claimed |
| US-20240016753-A1 | PHARMACEUTICAL COMPOSITIONS | FERRING B.V. (NL) | 2024-01-18 | — | — | US | claimed |
| WO-2023228116-A1 | INTRANASAL ADMINISTRATION OF THERMOSTABLE RNA VACCINES | ACCESS TO ADVANCED HEALTH INSTITUTE (US) | 2023-11-30 | — | — | WO | claimed |
| EP-4275678-A1 | METHOD FOR PREPARING TABLET OF PHARMACEUTICAL COMPOSITION COMPRISING TRIAZOLOPYRAZINE DERIVATIVE COMPOUND AS ACTIVE INGREDIENT | Abion Inc. (KR) | 2023-11-15 | — | — | EP | claimed |
| US-20230255893-A1 | FORMULATION TO DELIVER LIPOPHILIC ACTIVE INGREDIENTS | PERFORMS S.R.L. (IT) | 2023-08-17 | — | — | US | claimed |
| WO-2000003680-A2 | EMOLLIENT ESTERS BASED UPON CAPRYL ALCOHOL AND ISOSTEARIC ACID | BERNEL CHEMICAL COMPANY, INC. (US) | 2000-01-27 | — | — | WO | claimed |
| US-6001341-A | Deodorant and/or antiperspirant cosmetic compositions | CONDEA AUGUSTA S.P.A. (IT) | 1999-12-14 | — | — | US | claimed |
| WO-1999047128-A1 | BIPHASIC CONTROLLED RELEASE DELIVERY SYSTEM FOR HIGH SOLUBILITY PHARMACEUTICALS AND METHOD | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-09-23 | — | — | WO | claimed |
| US-5795695-A | PHOTO-QUALITY RECORDING | XEROX CORPORATION (US) | 1998-08-18 | — | — | US | claimed |
| EP-0492747-B1 | Pharmaceutical preparation for topical application | ROEMMERS SA (AR) | 1996-03-20 | — | — | EP | claimed |
| EP-0270503-B1 | UTILIZATION OF BROMURE D'OTILONIUM (DCI) FOR TOPIC APPLICATION IN THE GASTROINTESTINAL TRACT AND RELATIVE PHARMACEUTICAL FORMULATION APPROPRIATE FOR SUCH USE | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1993-09-15 | — | — | EP | claimed |
| EP-0270503-A2 | Utilization of bromure d'otilonium (DCI) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use | A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) | 1988-06-08 | — | — | EP | claimed |
| EP-0186453-A2 | A non-irritating cleansing composition | WARNER-LAMBERT COMPANY (US) | 1986-07-02 | — | — | EP | claimed |
| US-4490395-A | BLEND OF ISOBUTYLENE-ISOPRENE COPOLYMER, POLYUINYLACETATE, GLCERYL MONOSTEARATE AND WAYES | WARNER-LAMBERT COMPANY (US) | 1984-12-25 | — | — | US | claimed |
| US-4182686-A | ONE STEP EMULSION OF A FATTY ACID, AN ALKANOLAMINE, CETYL ALCOHOL, GLYCEROL MONOSTEARATE, AN ABRASIVE AND AN ACRYLIC RESIN FILLER | Laks, Sid (US) | 1980-01-08 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12611407-B2 | Gastro-resistant high-strength formulation containing posaconazole | RICTOR, CYP51A1, SI | GPR84 3295/4885FFAR1 250/4885MAPT 1596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.